• Seeking Alpha

ANI Pharmaceuticals Announces Initiation of Phase 4 Clinical Trial of Purified Cortrophin® Gel for the Treatment of Acute Gout Flares

Seeking Alpha / 1 hour from now 1 Views

Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of acute gout flares

Read more
  • Source:
  • GlobeNewswire - News about Public Companies
Previous post
CSW Industrials Reports Record Fiscal 2025 Fourth Quarter and Record Full Year Results
Next post
Instil Bio and ImmuneOnco Announced the Phase 2 Trial in First-line NSCLC of IMM2510/AXN-2510 (‘2510), a PD-L1xVEGF Bispecific Antibody, in Combination with Chemotherapy in China is on Track to Complete Enrollment in Q3 2025; Initial Results Anticipated i

Comments

Just Posted

  • Azerion Launches Open and Independent Multi-Cloud and AI Platform

    3 hours from now

  • Middlefield Canadian Income PCC: Net Asset Value(s)

    3 hours from now

  • Matachewan Announces Purchase and Sale Agreement to Mineral Royalties

    3 hours from now

  • Andrew Peller Ltd. Announces Timing of Q4 and Full Year Fiscal 2025 Results & Conference Call

    3 hours from now

  • Ledelses transaktioner

    3 hours from now

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Reviews

Categories

  • Seeking Alpha 1367

Categories

  • Seeking Alpha 1367

Pages

Tags

  • SA Transcripts
  • TOU:CA
  • Gold Mining Bull
  • TPZ
  • NG1:COM
  • CHK
  • TRMLF
  • fivn
  • CGIFF
  • CHE.UN:CA

Copyright News That Move � 2018. All Rights Reserved

  • Seeking Alpha
  • Trade Halts